These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24428293)

  • 1. Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.
    Giess CS; Yeh ED; Raza S; Birdwell RL
    Radiographics; 2014; 34(1):234-47. PubMed ID: 24428293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of nonmasslike enhancement at screening breast MR imaging of high-risk premenopausal women.
    Giess CS; Raza S; Birdwell RL
    Radiographics; 2013; 33(5):1343-60. PubMed ID: 24025928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
    Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
    Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.
    Choi BB; Kim SH
    Acta Radiol; 2015 Jul; 56(7):790-7. PubMed ID: 24951616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Diagn Interv Imaging; 2016 Mar; 97(3):315-20. PubMed ID: 26970658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
    King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
    Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
    Melsaether A; McDermott M; Gupta D; Pysarenko K; Shaylor SD; Moy L
    AJR Am J Roentgenol; 2014 Jul; 203(1):209-15. PubMed ID: 24951217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer.
    Telegrafo M; Rella L; Stabile Ianora AA; Angelelli G; Moschetta M
    Magn Reson Imaging; 2016 Feb; 34(2):173-6. PubMed ID: 26597834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
    Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
    Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
    Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
    Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Background parenchymal enhancement at breast MR imaging and breast cancer risk.
    King V; Brooks JD; Bernstein JL; Reiner AS; Pike MC; Morris EA
    Radiology; 2011 Jul; 260(1):50-60. PubMed ID: 21493794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.
    Kim EJ; Kang BJ; Kim SH; Youn IK; Baek JE; Lee HS
    Radiology; 2017 Sep; 284(3):656-666. PubMed ID: 28419815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
    Gokalp G; Topal U; Yildirim N; Tolunay S
    Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging.
    Kajihara M; Goto M; Hirayama Y; Okunishi S; Kaoku S; Konishi E; Shinkura N
    Magn Reson Med Sci; 2013 Mar; 12(1):39-45. PubMed ID: 23474960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
    Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue.
    Cho GY; Moy L; Kim SG; Klautau Leite AP; Baete SH; Babb JS; Sodickson DK; Sigmund EE
    Eur J Radiol; 2015 Oct; 84(10):1888-93. PubMed ID: 26220915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undiagnosed breast cancer at MR imaging: analysis of causes.
    Pages EB; Millet I; Hoa D; Doyon FC; Taourel P
    Radiology; 2012 Jul; 264(1):40-50. PubMed ID: 22523324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.
    King V; Kaplan J; Pike MC; Liberman L; David Dershaw D; Lee CH; Brooks JD; Morris EA
    Breast J; 2012; 18(6):527-34. PubMed ID: 23002953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast.
    Tozaki M; Yabuuchi H; Goto M; Sasaki M; Kubota K; Nakahara H
    Breast Cancer; 2021 Jul; 28(4):927-936. PubMed ID: 33625722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.